RE:RE:Hey PaulBioCloud is not a must-have-today technology. I am sure virus detection will become part of standard air quality assessment systems but their additional cost to those devices will have to be relatively marginal. A US$12K unit for a larger room in a world where government authorities dictate what restrictions you have to make is a "interesting, but no thank you" device. Beijing Olympics a couple of months away and following the experience of the recent summer Olympics, there sound like no bites. Steelcase, Marshall, Daikin and no early victories. I would have thought that these guys would have gotten some tangible early interest and soft-commitments prior to taking the effort to negotiate and enter into these distribution agreements. Right now it sounds like they can plug more products into their catalogues and there is not much to lose since their sales investment may constitute of giving sales folk info about it in a time span of hours and then it is just fielding inquiries if they come rather than setting up a sales organization dedicated to pushing it aggressively. Anyhow, for majority of places, BC is too expensive, but it is a big world. There may be some hope if a $12K unit can be integrated into the HVAC system and cover a larger, whole floor. For me, the core business is doing well and it sounds that it is very regional without having a foothold in many regions. So, expanding the core business into other and bigger regions (US?) is what would get me excited.
Rogg47 wrote: navajojoe wrote: If you can't sell BioCloud with Omicron ravaging the planet, what is the problem?
More than a year later, simple answer: there's NO market for Biocloud, wayyyy to expensive.... And pretty concerning that HC "july" results aren't out yet....